{"blog": [], "keywords": [{"value": "Ubl, Stephen J (1969- )", "name": "persons", "rank": "1", "is_major": "Y"}, {"value": "Pharmaceutical Research and Manufacturers of America", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Lobbying and Lobbyists", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/02/27/business/top-pharmaceutical-lobbyist-threads-a-thicket-of-outrage.html", "document_type": "article", "byline": {"person": [{"lastname": "PEAR", "firstname": "Robert", "role": "reported", "organization": "", "rank": 1}], "original": "By ROBERT PEAR"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbWide.jpg", "legacy": {"wide": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-articleLarge.jpg", "legacy": {"xlarge": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-articleLarge.jpg", "xlargeheight": "421", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 421}, {"url": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/02/27/business/27LOBBYIST-new/27LOBBYIST-1456522917158-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1401", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Stephen Ubl, who became head of the Pharmaceutical Research and Manufacturers of America late last year, is facing rising criticism of the industry.", "pub_date": "2016-02-27T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Lobbying for Drug Makers, and Fending Off Anger Over Prices", "main": "Top Lobbyist for Drug Makers Threads a Thicket of Outrage"}, "print_page": "1", "snippet": "Stephen Ubl, who became head of the Pharmaceutical Research and Manufacturers of America late last year, is facing rising criticism of the industry.", "_id": "56d08f2638f0d83825735999", "slideshow_credits": null, "abstract": "Stephen J Ubl, new president and chief executive of Pharmaceutical Research and Manufacturers of America, is working to lobby for drug makers while fending off populist anger over exorbitant prices."}